Pharmaceutical Inc Biomarin is 10% at LA JOLLA PHARMACEUTICAL CO (LJPC). They have made 3 open-market trades across 3 companies since 2009, most recently 2026-09-02.
CIK 0001048477
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.8M since 2012, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CPRX | 6,666,667 | $209.9M |
| LJPC | 10,173,120 | $63.3M |
| BMRN | 61,003 | $3.3M |
| Total | $276.5M |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.